发明申请
US20060234347A1 Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors
审中-公开
针对使用可溶性酪氨酸激酶受体进行癌症治疗的多种血管生成途径
- 专利标题： Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors
- 专利标题（中）： 针对使用可溶性酪氨酸激酶受体进行癌症治疗的多种血管生成途径
-
申请号： US11401340申请日： 2006-04-10
-
公开(公告)号： US20060234347A1公开(公告)日： 2006-10-19
- 发明人: Thomas Harding , Minh Nguyen
- 申请人： Thomas Harding , Minh Nguyen
- 主分类号： C12P21/06
- IPC分类号： C12P21/06 ; C07H21/04 ; C07K14/71 ; C12N15/86
摘要：
Multivalent soluble receptor proteins that bind to more than one angiogenic factor are described. Nucleotide and vector sequences which encode the multivalent soluble receptor protein, as well as host cells which comprise them and methods of making and using them are also described. The multivalent soluble receptor proteins and vectors which encode them find utility in treatment of cancer and other diseases associated with angiogenesis.
信息查询
